Latest filings (excl ownership)
6-K
Current report (foreign)
1 Mar 24
6-K
Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
20 Feb 24
6-K
Material Change Report
16 Feb 24
6-K
Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
8 Feb 24
6-K
Condensed Consolidated Interim Financial Statements
8 Feb 24
6-K
Aurora Cannabis Acquires MedReleaf Australia
8 Feb 24
6-K
Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call
31 Jan 24
6-K
Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA
9 Nov 23
6-K
Condensed Consolidated Interim Financial Statements
9 Nov 23
6-K
Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call
27 Oct 23
6-K
Aurora Cannabis Inc. Announces Closing of its C$38.8 Million Bought Deal Financing, Including the Full Exercise of the Over-Allotment Option
3 Oct 23
6-K
Aurora Cannabis Inc. Announces C$34 Million Bought Deal Financing
28 Sep 23
6-K
Current report (foreign)
19 Sep 23
6-K
Current report (foreign)
8 Sep 23
6-K
Aurora Cannabis Announces Results of 2023 Annual General Meeting
14 Aug 23
6-K
Condensed Consolidated Interim Financial Statements
10 Aug 23
6-K
Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and Delivers Record Positive Adjusted EBITDA
10 Aug 23
6-K
Aurora Cannabis to Host First Quarter Fiscal Year 2024 Investor Conference Call
27 Jul 23
6-K
Aurora Cannabis Announces Sale of Aurora Sun Facility to Bevo Expected to Provide Incremental Revenue and Cash Flow
24 Jul 23
6-K
Current report (foreign)
19 Jul 23
6-K
Current report (foreign)
10 Jul 23
40-F
2022 FY
Annual report (Canada)
14 Jun 23
6-K
Aurora Cannabis Announces Fiscal 2023 Third Quarter and Files Full Year Results
14 Jun 23
6-K
Aurora Cannabis to Host Third Quarter and Fiscal Year 2023 Investor Conference Call and File Related Year End Information
7 Jun 23
6-K
Current report (foreign)
25 May 23
6-K
Current report (foreign)
28 Apr 23
6-K
Current report (foreign)
27 Apr 23
SUPPL
Supplemental materials (foreign)
27 Apr 23
SUPPL
Supplemental materials (foreign)
27 Apr 23
SUPPL
Supplemental materials (foreign)
27 Apr 23
F-X
Appointment of agent for service of process by issuers registering securities
27 Apr 23
F-10
Registration of securities (Canada)
27 Apr 23
6-K
Current report (foreign)
24 Apr 23
6-K
Current report (foreign)
30 Mar 23
6-K
Aurora Provides Update on Nasdaq Listing
24 Mar 23
6-K
Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus
17 Mar 23
6-K
Aurora and MedReleaf Australia Launch new Medical Cannabis Brand - CraftPlant
22 Feb 23
6-K
Current report (foreign)
10 Feb 23
6-K
Aurora Cannabis Announces Fiscal 2023 Second Quarter Results
9 Feb 23
6-K
Aurora Cannabis to Host Second Quarter Fiscal Year 2023 Investor Conference Call
26 Jan 23